Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Return on Capital Employed (2020 - 2023)

Historic Return on Capital Employed for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to 0.77%.

  • Therapeutics' Return on Capital Employed fell 3900.0% to 0.77% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.77%, marking a year-over-year decrease of 3900.0%. This contributed to the annual value of 0.64% for FY2023, which is 2500.0% down from last year.
  • As of Q4 2023, Therapeutics' Return on Capital Employed stood at 0.77%, which was down 3900.0% from 0.63% recorded in Q3 2023.
  • Therapeutics' 5-year Return on Capital Employed high stood at 0.3% for Q3 2021, and its period low was 0.77% during Q4 2023.
  • Over the past 4 years, Therapeutics' median Return on Capital Employed value was 0.41% (recorded in 2022), while the average stood at 0.46%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 1500bps in 2022, then crashed by -3900bps in 2023.
  • Quarter analysis of 4 years shows Therapeutics' Return on Capital Employed stood at 0.47% in 2020, then increased by 26bps to 0.35% in 2021, then decreased by -10bps to 0.38% in 2022, then plummeted by -101bps to 0.77% in 2023.
  • Its Return on Capital Employed stands at 0.77% for Q4 2023, versus 0.63% for Q3 2023 and 0.48% for Q2 2023.